Latest NexCAR19 News & Updates

New Delhi, July 15 (IANS) India-origin pharmaceutical patent families have risen more than four-fold over the past decade, while the country’s drug discovery pipeline has expanded to more than 1,095 programmes across 195 companies, signalling a rapid shift from generics-led manufacturing to innovation-driven research, a report showed on Wednesday.According to a joint report by Boston Consulting Group (BCG) and HealthKois, the country is at a juncture where the next five years will determine whet…